Northwest & Ethical Investments’s Alignment Healthcare ALHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$242K Sell
10,412
-11,329
-52% -$217K 0.01% 388
2026
Q1
$406K Buy
21,741
+170
+0.8% +$3.41K 0.01% 419
2025
Q4
$415K Sell
21,571
-2,349
-10% -$42.2K 0.01% 413
2025
Q3
$417K Buy
+23,920
New +$355K 0.01% 419

Other funds holding ALHC

Northwest & Ethical Investments's ALHC Position: Q2 2026 in Review

Northwest & Ethical Investments reduced its Alignment Healthcare (ALHC) stake by 52% in Q2 2026, selling an estimated $217K and leaving 10,412 shares worth $242K. The position accounts for 0.01% of the portfolio, ranked #388.

Northwest & Ethical Investments first reported a position in ALHC in Q3 2025 and has held it in 4 quarters since. The position peaked at $417K in Q3 2025. 323 funds tracked by Wall St. Rank hold ALHC as of Q2 2026.

  • Northwest & Ethical Investments held 10,412 shares of Alignment Healthcare worth $242K as of Q2 2026.
  • Northwest & Ethical Investments sold 11,329 Alignment Healthcare shares in Q2 2026, an estimated $217K.
  • Alignment Healthcare made up 0.01% of Northwest & Ethical Investments's portfolio in Q2 2026, its #388 holding.
  • Northwest & Ethical Investments first reported a position in Alignment Healthcare in Q3 2025 and has held it in 4 quarters since.
  • Northwest & Ethical Investments's Alignment Healthcare position peaked at $417K in Q3 2025.
  • 323 funds tracked by Wall St. Rank held Alignment Healthcare as of Q2 2026.

Based on Northwest & Ethical Investments's 13F filing for Q2 2026, filed 13 Aug 2026.